Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.780
Filter
1.
J Med Case Rep ; 18(1): 340, 2024 Jul 13.
Article in English | MEDLINE | ID: mdl-38997777

ABSTRACT

BACKGROUND: This case highlights several complications of a late and rare presentation of culture-negative Streptococcus pyogenes endocarditis of a previously repaired mitral valve with an annuloplasty ring including recurrent cardioembolic strokes, which was initially missed on transthoracic echocardiography. CASE PRESENTATION: A 66-year-old Caucasian female with prior mitral valve prolapse status post mitral valve annuloplasty and left atrial appendage occlusion, followed by two strokes, presented with supraventricular tachycardia that resolved spontaneously. During an inpatient admission, she developed symptoms of another stroke, and imaging studies were suggestive of recurrent cardioembolic phenomenon. Additional workup revealed two small intra-atrial masses adherent to the mitral annuloplasty ring missed on prior evaluation for recurrent stroke. She underwent surgical repair in the setting of a chronic culture-negative infectious endocarditis with Streptococcus pyogenes and recovered well with no further cardioembolic phenomenon. CONCLUSION: This case serves to highlight the importance of having a higher index of suspicion in any cardiac prosthesis patient for endocarditis when presenting with symptoms such as recurrent stroke, arrhythmias, and abnormal cardiac lab work. It also demonstrates the need for appropriate imaging with transthoracic echocardiography followed by transesophageal echocardiography and reviews surgical indications to diagnose and treat culture-negative endocarditis.


Subject(s)
Echocardiography , Endocarditis, Bacterial , Streptococcal Infections , Streptococcus pyogenes , Humans , Female , Aged , Streptococcus pyogenes/isolation & purification , Streptococcal Infections/diagnostic imaging , Endocarditis, Bacterial/diagnostic imaging , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/surgery , Mitral Valve Annuloplasty , Mitral Valve Prolapse/surgery , Mitral Valve Prolapse/diagnostic imaging , Echocardiography, Transesophageal , Mitral Valve/surgery , Mitral Valve/diagnostic imaging , Prosthesis-Related Infections/diagnostic imaging , Prosthesis-Related Infections/microbiology , Prosthesis-Related Infections/surgery
2.
Vet Med Sci ; 10(4): e1501, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38923315

ABSTRACT

INTRODUCTION: Silica-sprayed tubes (SSTs) are often used to transport synovial fluid samples in equine practice. They promote the coagulation of the sample. The objective of the study is to evaluate the effect of SST on bacterial culture. MATERIALS AND METHODS: The study was divided into two parts: sterile saline (Part A) and synovial fluid (Part B). Four common bacteria associated with equine synovial sepsis were used: Streptococcus pyogenes, Escherichia coli, Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). Three collection tubes were used: STT, plain (no-additives) and brain and heart infusion (BHI) broth. Bacteria were cultured in horse blood agar plates for 48 h. Outcome variables were negative culture, positive culture and total number of colony-forming units (CFUs). Statistical analysis was performed using Mann-Whitney U test, and significance was set at p < 0.05. RESULTS: The total number of agar plates read was 1557 (779 saline; 778 synovial fluid). Total negative cultures were 25/779 on saline and 3/778 on synovial fluid. In broth, maximum growth CFU was achieved after 8 h for both saline and synovial fluid for all bacteria. S. pyogenesand E. coli produced a significantly lower number of CFU when in SST compared to plain or broth after 4 h, whereas S. aureus (American Type Culture Collection [ATCC] and MRSA) only after 24 h. DISCUSSION: Silica-containing tubes reduced bacterial proliferation, whereas the use of a BHI broth provided the highest bacterial load in the sample. The use of SST may have a negative effect on bacterial proliferation in samples obtained from clinical cases.


Subject(s)
Silicon Dioxide , Synovial Fluid , Synovial Fluid/microbiology , Animals , Horses , Silicon Dioxide/chemistry , Specimen Handling/methods , Specimen Handling/veterinary , Escherichia coli/drug effects , Escherichia coli/physiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology , Staphylococcus aureus/isolation & purification , Bacteriological Techniques/veterinary , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/isolation & purification , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/isolation & purification
3.
PLoS One ; 19(6): e0304861, 2024.
Article in English | MEDLINE | ID: mdl-38917227

ABSTRACT

Pleural empyema is a serious complication of pneumonia in children. Negative bacterial cultures commonly impede optimal antibiotic therapy. To improve bacterial identification, we developed a molecular assay and evaluated its performance compared with bacterial culture. Our multiplex-quantitative PCR to detect Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus and Haemophilus influenzae was assessed using bacterial genomic DNA and laboratory-prepared samples (n = 267). To evaluate clinical performance, we conducted the Molecular Assessment of Thoracic Empyema (MATE) observational study, enrolling children hospitalised with empyema. Pleural fluids were tested by bacterial culture and multiplex-qPCR, and performance determined using a study gold standard. We determined clinical sensitivity and time-to-organism-identification to assess the potential of the multiplex-qPCR to reduce the duration of empiric untargeted antibiotic therapy. Using spiked samples, the multiplex-qPCR demonstrated 213/215 (99.1%) sensitivity and 52/52 (100%) specificity for all organisms. During May 2019-March 2023, 100 children were enrolled in the MATE study; median age was 3.9 years (IQR 2-5.6). A bacterial pathogen was identified in 90/100 (90%) specimens by multiplex-qPCR, and 24/100 (24%) by bacterial culture (P <0.001). Multiplex-qPCR identified a bacterial cause in 68/76 (90%) culture-negative specimens. S. pneumoniae was the most common pathogen, identified in 67/100 (67%) specimens. We estimate our multiplex-qPCR would have reduced the duration of untargeted antibiotic therapy in 61% of cases by a median 20 days (IQR 17.5-23, range 1-55). Multiplex-qPCR significantly increased pathogen detection compared with culture and may allow for reducing the duration of untargeted antibiotic therapy.


Subject(s)
Empyema, Pleural , Multiplex Polymerase Chain Reaction , Humans , Child, Preschool , Empyema, Pleural/microbiology , Empyema, Pleural/drug therapy , Empyema, Pleural/diagnosis , Male , Female , Multiplex Polymerase Chain Reaction/methods , Child , Haemophilus influenzae/genetics , Haemophilus influenzae/isolation & purification , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/drug effects , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/isolation & purification , Streptococcus pyogenes/genetics , Streptococcus pyogenes/isolation & purification , Infant , Hospitalization , Anti-Bacterial Agents/therapeutic use , Sensitivity and Specificity , DNA, Bacterial/genetics
4.
J Infect Public Health ; 17(7): 102461, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38852231

ABSTRACT

Endogenous bacterial endophthalmitis (EE) is an intraocular infection with a poor prognosis. Timely diagnosis and prompt treatment are crucial to prevent vision loss. In this communication, we describe a case of EE caused by Streptococcus pyogenes (Group A Streptococcus [GAS]) in an HIV-positive patient with poorly controlled type 2 diabetes mellitus (DM). A 60-year-old man with a history of HIV and poorly controlled type 2 diabetes, presented with progressive blurry vision, left eye pain, redness, and headache. EE was diagnosed based on the clinical presentation and gram stain analysis of blood culture. Treatment with vitreous tap, intravitreal, topical antibiotics, and systemic antibiotics significantly improved the patient's symptoms. The case highlights the rarity of GAS as a causative agent of EE, particularly in patients with risk factors such as HIV infection and DM.


Subject(s)
Anti-Bacterial Agents , Diabetes Mellitus, Type 2 , Endophthalmitis , HIV Infections , Streptococcal Infections , Streptococcus pyogenes , Humans , Endophthalmitis/microbiology , Endophthalmitis/drug therapy , Endophthalmitis/diagnosis , Male , Middle Aged , HIV Infections/complications , HIV Infections/drug therapy , Diabetes Mellitus, Type 2/complications , Anti-Bacterial Agents/therapeutic use , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/complications
6.
Pediatr Ann ; 53(6): e234-e238, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38852075

ABSTRACT

The purpose of this review is to summarize the current evidence regarding the management of streptococcal pharyngitis in children. This article aims to provide a valid support to discriminate streptococcal pharyngitis from viral cases and treat it appropriately to avoid the development of complications. Differential diagnosis based only on clinical features is not always easy. For this reason, different clinical scores were created to provide an accurate diagnosis. Microbiological tests are valuable tools as well, but their use is not recommended unanimously. Concerning treatment, all guidelines agree on the drug to be used. However, doubts remain about the optimal duration of antibiotic therapy, especially in this specific historical moment as we are experiencing a peak in streptococcal infections. [Pediatr Ann. 2024;53(6):e234-e238.].


Subject(s)
Anti-Bacterial Agents , Pharyngitis , Streptococcal Infections , Streptococcus pyogenes , Humans , Pharyngitis/diagnosis , Pharyngitis/drug therapy , Pharyngitis/microbiology , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Child , Anti-Bacterial Agents/therapeutic use , Streptococcus pyogenes/isolation & purification , Diagnosis, Differential
7.
J Infect ; 89(2): 106201, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38897241

ABSTRACT

OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has necessitated significant changes in medical systems, social behaviours, and non-pharmaceutical interventions (NPIs). We aimed to determine the effect of the COVID-19 pandemic on changes in the epidemiology of respiratory-transmitted bacteria that have been unexplored. METHODS: We utilised a comprehensive national surveillance database from 2018 to 2021 to compare monthly number of patients with four respiratory-transmitted human-to-human bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes) before and after the COVID-19 pandemic, stratified by specimen sources and age groups. RESULTS: The incidence of detected patients with S. pneumoniae, H. influenzae, and S. pyogenes from both respiratory and blood cultures significantly decreased from 2019 to 2020. In 2021, the incidence of detected patients with the respiratory-transmitted bacterial species, except for S. pyogenes, from respiratory cultures, increased again from April to July, primarily affecting the 0-4-year age group. CONCLUSIONS: Our comprehensive national surveillance data analysis demonstrates the dynamic changes and effects of NPIs on respiratory-transmitted bacteria during the COVID-19 pandemic, with variations observed among species, specimen sources, and age groups.


Subject(s)
COVID-19 , Respiratory Tract Infections , SARS-CoV-2 , Streptococcus pyogenes , Humans , COVID-19/epidemiology , COVID-19/transmission , Child, Preschool , Infant , Child , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/transmission , Respiratory Tract Infections/virology , Adult , Streptococcus pyogenes/isolation & purification , Adolescent , Middle Aged , Haemophilus influenzae/isolation & purification , Incidence , Infant, Newborn , Streptococcus pneumoniae/isolation & purification , Young Adult , Aged , Moraxella catarrhalis/isolation & purification , Male , Female , Bacterial Infections/epidemiology , Bacterial Infections/transmission , Pandemics
8.
Infect Dis Now ; 54(5): 104934, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38825046

ABSTRACT

OBJECTIVES: In our investigation of an episode of clustered acute epiglottitis occurring in Vendée, western France, between October and December 2022, we described the reported cases and confirmed its unusual character at several geographic levels. METHODS: The investigation relied on three data sources: hospitalization and emergency department reports; national reference centre data; and data from the French syndromic surveillance system. RESULTS: The six patients were male, with an average age of 42 years [32-66]; all were hospitalized in an ICU, and one of them died. Documented risk factors for epiglottitis (active smoking, regular alcohol consumption, overweight) were present in the majority of cases. No causal pathogen was identified. Syndromic surveillance data confirmed increased acute epiglottitis at the local, regional and national levels. CONCLUSION: We not only characterized the episode of serious clustered acute epiglottitis in Vendée, but also observed a nationwide increase in this pathology occurring concomitantly with increased circulation in France of streptococcus A.


Subject(s)
Epiglottitis , Humans , Epiglottitis/epidemiology , France/epidemiology , Male , Adult , Middle Aged , Acute Disease , Aged , Risk Factors , Streptococcal Infections/epidemiology , Hospitalization/statistics & numerical data , Streptococcus pyogenes/isolation & purification , Smoking/epidemiology , Smoking/adverse effects , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology
9.
Microb Genom ; 10(5)2024 May.
Article in English | MEDLINE | ID: mdl-38739120

ABSTRACT

Cutaneous ulcers are common in yaws-endemic areas. Although often attributed to 'Treponema pallidum subsp. pertenue' and Haemophilus ducreyi, quantitative PCR has highlighted a significant proportion of these ulcers are negative for both pathogens and are considered idiopathic. This is a retrospective analysis utilising existing 16S rRNA sequencing data from two independent yaws studies that took place in Ghana and the Solomon Islands. We characterized bacterial diversity in 38 samples to identify potential causative agents for idiopathic cutaneous ulcers. We identified a diverse bacterial profile, including Arcanobacterium haemolyticum, Campylobacter concisus, Corynebacterium diphtheriae, Staphylococcus spp. and Streptococcus pyogenes, consistent with findings from previous cutaneous ulcer microbiome studies. No single bacterial species was universally present across all samples. The most prevalent bacterium, Campylobacter ureolyticus, appeared in 42% of samples, suggesting a multifactorial aetiology for cutaneous ulcers in yaws-endemic areas. This study emphasizes the need for a nuanced understanding of potential causative agents. The findings prompt further exploration into the intricate microbial interactions contributing to idiopathic yaw-like ulcers, guiding future research toward comprehensive diagnostic and therapeutic strategies.


Subject(s)
Microbiota , RNA, Ribosomal, 16S , Skin Ulcer , Humans , RNA, Ribosomal, 16S/genetics , Skin Ulcer/microbiology , Ghana , Male , Yaws/microbiology , Yaws/diagnosis , Retrospective Studies , Female , Adult , Bacteria/genetics , Bacteria/classification , Bacteria/isolation & purification , Melanesia , Middle Aged , Staphylococcus/genetics , Staphylococcus/isolation & purification , Staphylococcus/classification , Streptococcus pyogenes/genetics , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/classification , Arcanobacterium/genetics , Arcanobacterium/isolation & purification , Campylobacter/genetics , Campylobacter/isolation & purification , Campylobacter/classification
10.
Talanta ; 276: 126221, 2024 Aug 15.
Article in English | MEDLINE | ID: mdl-38776768

ABSTRACT

Streptococcus pyogenes (Group A Streptococcus; GAS) is a Gram-positive bacterium responsible for substantial human mortality and morbidity. Conventional diagnosis of GAS pharyngitis relies on throat swab culture, a low-throughput, slow, and relatively invasive 'gold standard'. While molecular approaches are becoming increasingly utilized, the potential of saliva as a diagnostic fluid for GAS infection remains largely unexplored. Here, we present a novel, high-throughput, sensitive, and robust speB qPCR assay that reliably detects GAS in saliva using innovative 3base™ technology (Genetic Signatures Limited, Sydney, Australia). The assay has been validated on baseline, acute, and convalescent saliva samples generated from the Controlled Human Infection for Vaccination Against Streptococcus (CHIVAS-M75) trial, in which healthy adult participants were challenged with emm75 GAS. In these well-defined samples, our high-throughput assay outperforms throat culture and conventional qPCR in saliva respectively, affirming the utility of the 3base™ platform, demonstrating the feasibility of saliva as a diagnostic biofluid, and paving the way for the development of novel non-invasive approaches for the detection of GAS and other oropharyngeal pathogens.


Subject(s)
Pharyngitis , Saliva , Streptococcus pyogenes , Humans , Streptococcus pyogenes/isolation & purification , Saliva/microbiology , Pharyngitis/microbiology , Pharyngitis/diagnosis , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Adult , Real-Time Polymerase Chain Reaction/methods
11.
Microbiol Spectr ; 12(7): e0426523, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38785764

ABSTRACT

The disease burden of Streptococcus pyogenes is particularly high in low- and middle-income countries. However, data on the molecular epidemiology of S. pyogenes in such regions, especially sub-Saharan Africa, are scarce. To address this, whole-genome sequencing (WGS) of S. pyogenes from Gabon was performed to identify transmission clusters and provide valuable genomic data for public repositories. A total of 76 S. pyogenes isolates from 73 patients, collected between September 2012 and January 2013, were characterized by short-read whole-genome sequencing. The predominant emm types were emm58.0, emm81.2 and emm223.0 with 9.2% (7 of 76), 7.9% (6 of 76), and 6.6% (5 of 76), respectively. Single-nucleotide polymorphism analysis revealed 16 putative transmission clusters. Four of these were household transmissions. Four antimicrobial genes (lmrP, tetM, tetL, and thfT) were found in the S. pyogenes isolates from this study. All strains carried lmrP. Of the 76 isolates, 64 (84.2%) carried at least one tetracycline resistance gene (tetM or tetL). Comparisons with other publicly available African genomic data revealed a significant correlation between geographical location and genetic diversity of S. pyogenes, with Gabonese strains showing similarities to those from Kenya and certain Oceanian regions. Our study showed that transmission of S. pyogenes can occur at the community/household level and that high-resolution molecular typing is needed to monitor changes in circulating clones and to detect community outbreaks. Advocacy for the adoption of WGS for comprehensive molecular characterization of S. pyogenes and data sharing through public repositories should be encouraged to understand the molecular epidemiology and evolutionary trajectory of S. pyogenes in sub-Saharan Africa. IMPORTANCE: The study conducted in Gabon underscores the critical importance of addressing the limited knowledge of the molecular epidemiology of Streptococcus pyogenes in low- and middle-income countries, particularly sub-Saharan Africa. Our molecular analysis identified predominant emm types and unveiled 16 putative transmission clusters, four involving household transmissions. Furthermore, the study revealed a correlation between geographical location and genetic diversity, emphasizing the necessity for a comprehensive understanding of the molecular epidemiology and evolutionary trajectory of S. pyogenes in various regions. The call for advocacy in adopting whole-genome sequencing for molecular characterization and data sharing through public repositories is crucial for advancing our knowledge and implementing effective strategies to combat the spread of S. pyogenes in sub-Saharan Africa.


Subject(s)
Molecular Epidemiology , Pharynx , Streptococcal Infections , Streptococcus pyogenes , Whole Genome Sequencing , Humans , Streptococcus pyogenes/genetics , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/classification , Gabon/epidemiology , Pharynx/microbiology , Streptococcal Infections/microbiology , Streptococcal Infections/epidemiology , Streptococcal Infections/transmission , Child , Child, Preschool , Adolescent , Male , Female , Adult , Polymorphism, Single Nucleotide , Young Adult , Skin/microbiology , Infant , Genome, Bacterial , Middle Aged , Genomics , Aged
12.
Clin Microbiol Infect ; 30(8): 1074.e1-1074.e4, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38759867

ABSTRACT

OBJECTIVES: To test the prevailing dogma that Streptococcus pyogenes emm-types that cause pharyngitis are the same as those associated with the carriage, using a global dataset. METHODS: Drawing on our systematic review of the global distribution of S. pyogenes emm-types and emm-clusters from 1990 to 2023, we compared the distribution and diversity of strains associated with pharyngitis and pharyngeal carriage, in the context of local United Nations Development Programme Human Development Index (HDI) values. RESULTS: We included 20 222 isolates from 71 studies done in 34 countries, with the vast majority of carriage strain data from studies in 'Low HDI' settings (550/1293; 43%). There was higher emm-type diversity for carriage than pharyngitis strains (Simpson Reciprocal Index of diversity 28.9 vs. 11.4). Compared with pharyngitis strains, carriage emm-types were disproportionately from emm-clusters E and D, usually described as 'generalist' or 'skin' strains. DISCUSSION: A limited number of studies have compared S. pyogenes strains from cases of pharyngitis compared with carriage. Our understanding of strains associated with carriage is the poorest for high-income settings. In low and medium HDI countries, we found greater strain associated with pharyngeal carriage than pharyngitis. Improving our understanding of S. pyogenes carriage epidemiology in the pre-vaccine era will help to decipher the direct and potential indirect effects of vaccines.


Subject(s)
Antigens, Bacterial , Bacterial Outer Membrane Proteins , Carrier Proteins , Carrier State , Pharyngitis , Streptococcal Infections , Streptococcus pyogenes , Streptococcus pyogenes/genetics , Streptococcus pyogenes/classification , Streptococcus pyogenes/isolation & purification , Humans , Pharyngitis/microbiology , Pharyngitis/epidemiology , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Carrier State/microbiology , Carrier State/epidemiology , Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Carrier Proteins/genetics , Pharynx/microbiology , Global Health
13.
Lancet Microbe ; 5(7): 679-688, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38735305

ABSTRACT

BACKGROUND: Streptococcus pyogenes causes more than 500 000 deaths per year globally, which occur disproportionately in low-income and middle-income countries. The roles of S pyogenes skin and pharyngeal carriage in transmission are unclear. We aimed to investigate the clinical epidemiology and household transmission dynamics of both S pyogenes asymptomatic carriage and infection in a high-burden setting. METHODS: We did a 1-year prospective, longitudinal, household cohort study, recruiting healthy participants from households in Sukuta, The Gambia. Households were eligible if they comprised at least three members, including one child younger than 18 years, and were excluded if more than half of household members declined to participate. Households were identified by random GPS coordinates derived from census data. At monthly visits, pharyngeal and normal skin swabs were collected for S pyogenes culture, and sociodemographic data were recorded by interview. Incident pharyngitis and pyoderma infections were captured. Cultured isolates underwent emm genotyping. The primary outcome measures were incidence of S pyogenes carriage and disease. Additional outcomes were prevalence of S pyogenes skin and pharyngeal carriage, S pyogenes skin and pharyngeal clearance time, S pyogenes emm type, risk factors for carriage and disease events, household secondary attack rate, and emm-linked household transmission events. The study is registered on ClinicalTrials.gov, NCT05117528. FINDINGS: Between July 27, 2021, and Sept 28, 2022, 442 participants were enrolled from 44 households. The median age was 15 years (IQR 6-28) and 233 (53%) were female. We identified 17 pharyngitis and 99 pyoderma events and 49 pharyngeal and 39 skin S pyogenes carriage acquisition events. Mean monthly prevalence was 1·4% (95% CI 1·1-1·9) for S pyogenes pharyngeal carriage and 1·2% (0·9-1·6) for S pyogenes skin carriage. Incidence was 120 per 1000 person-years (95% CI 87-166) for S pyogenes pharyngeal carriage, 124 per 1000 person-years (90-170) for S pyogenes skin carriage, 51 per 1000 person-years (31-84) for S pyogenes pharyngitis, and 263 per 1000 person-years (212-327) for S pyogenes pyoderma. Pharyngeal carriage risk was higher during the rainy season (HR 5·67, 95% CI 2·19-14·69) and in larger households (per additional person: 1·03, 1·00-1·05), as was pharyngitis risk (rainy season: 3·00, 1·10-8·22; household size: 1·04, 1·02-1·07). Skin carriage risk was not affected by season or household size, but was lower in female than in male participants (0·45, 0·22-0·92) and highest in children younger than 5 years compared with adults (22·69, 3·08-167·21), with similar findings for pyoderma (female sex: 0·34, 0·19-0·61; age <5 years: 7·00, 2·78-17·64). Median clearance time after carriage acquisition was 4·0 days for both skin (IQR 3·5-7·0) and pharynx (3·5-7·3). The mean household secondary attack rate was 4·9 (95% CI 3·5-6·3) for epidemiologically linked S pyogenes events and 0·74 (0·3-1·2) for emm-linked S pyogenes events. Of the 204 carriage and disease events, emm types were available for 179 (88%). Only 18 emm-linked between-visit household transmission events were identified. Pyoderma was the most common source of S pyogenes household transmissions in 11 (61%) of 18 emm-linked transmissions. Both pharynx to skin and skin to pharynx transmission events were observed. INTERPRETATION: S pyogenes carriage and infection are common in The Gambia, particularly in children. Most events are non-household acquisitions, but skin carriage and pyoderma have an important role in S pyogenes household transmission and bidirectional transmission between skin and pharynx occurs. FUNDING: Wellcome Trust, Chadwick Trust, Fonds National de la Recherche Scientifique (Belgium), European Society for Paediatric Infectious Diseases, and Medical Research Council (UK).


Subject(s)
Carrier State , Family Characteristics , Pharynx , Streptococcal Infections , Streptococcus pyogenes , Humans , Streptococcus pyogenes/isolation & purification , Gambia/epidemiology , Female , Longitudinal Studies , Male , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcal Infections/transmission , Carrier State/epidemiology , Carrier State/microbiology , Child , Adult , Adolescent , Prospective Studies , Young Adult , Child, Preschool , Pharynx/microbiology , Prevalence , Incidence , Risk Factors , Pharyngitis/microbiology , Pharyngitis/epidemiology , Skin/microbiology , Cohort Studies , Pyoderma/epidemiology , Pyoderma/microbiology , Middle Aged , Infant
14.
Int J Infect Dis ; 145: 107100, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38762046

ABSTRACT

OBJECTIVES: The objective was to estimate the probability that finding a Streptococcus pyogenes (Group A Streptococcus) in a throat swab in a patient with a sore throat reflects the aetiology. We also investigated to what extent this is influenced by age, carrier rates of S. pyogenes and climate zone. METHODS: We conducted a comprehensive search of Medline and Scopus up until October 2023 for case-control studies reporting the prevalence of S. pyogenes in patients with a sore throat and healthy controls. We only included studies with separate data for children and adults. We used the positive and negative etiologic predictive values (P-EPV and N-EPV) to estimate the probability of a link between a sore throat and a finding of S. pyogenes. RESULTS: We included 15 studies in our meta-analysis. The overall P-EPV for children and adults were 63% (49-74%) and 92% (87-95%), respectively. The P-EPV rose to 83% (64-93%) for children and 94% (90-97%) for adults when only patients with 3-4 Centor criteria were included. The overall N-EPV was 97% (96-98%) for children and 96% (95-97%) for adults. CONCLUSION: Detecting S. pyogenes in adult patients with an uncomplicated acute sore throat is useful to rule in S. pyogenes as the likely aetiologic agent. The P-EPV significantly increased for children when those with 3-4 Centor criteria were selected. A negative throat swab is always useful for both children and adults to rule out S. pyogenes as the cause of sore throat.


Subject(s)
Pharyngitis , Streptococcal Infections , Streptococcus pyogenes , Humans , Streptococcus pyogenes/isolation & purification , Pharyngitis/microbiology , Pharyngitis/diagnosis , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Streptococcal Infections/epidemiology , Child , Adult , Carrier State/microbiology , Carrier State/epidemiology , Pharynx/microbiology , Prevalence
15.
Isr Med Assoc J ; 26(5): 299-303, 2024 May.
Article in English | MEDLINE | ID: mdl-38736345

ABSTRACT

BACKGROUND: Group A Streptococcus (GAS) is the predominant bacterial pathogen of pharyngitis in children. However, distinguishing GAS from viral pharyngitis is sometimes difficult. Unnecessary antibiotic use contributes to unwanted side effects, such as allergic reactions and diarrhea. It also may increase antibiotic resistance. OBJECTIVES: To evaluate the effect of a machine learning algorithm on the clinical evaluation of bacterial pharyngitis in children. METHODS: We assessed 54 children aged 2-17 years who presented to a primary healthcare clinic with a sore throat and fever over 38°C from 1 November 2021 to 30 April 2022. All children were tested with a streptococcal rapid antigen detection test (RADT). If negative, a throat culture was performed. Children with a positive RADT or throat culture were considered GAS-positive and treated antibiotically for 10 days, as per guidelines. Children with negative RADT tests throat cultures were considered positive for viral pharyngitis. The children were allocated into two groups: Group A streptococcal pharyngitis (GAS-P) (n=36) and viral pharyngitis (n=18). All patients underwent a McIsaac score evaluation. A linear support vector machine algorithm was used for classification. RESULTS: The machine learning algorithm resulted in a positive predictive value of 80.6 % (27 of 36) for GAS-P infection. The false discovery rates for GAS-P infection were 19.4 % (7 of 36). CONCLUSIONS: Applying the machine-learning strategy resulted in a high positive predictive value for the detection of streptococcal pharyngitis and can contribute as a medical decision aid in the diagnosis and treatment of GAS-P.


Subject(s)
Machine Learning , Pharyngitis , Streptococcal Infections , Streptococcus pyogenes , Humans , Pharyngitis/microbiology , Pharyngitis/diagnosis , Child , Pilot Projects , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Child, Preschool , Male , Female , Streptococcus pyogenes/isolation & purification , Adolescent , Decision Support Systems, Clinical , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Acute Disease , Diagnosis, Differential , Algorithms
16.
Nat Commun ; 15(1): 3916, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38729927

ABSTRACT

The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1UK to be the dominant source of invasive infections in this upsurge. Compared with ancestral M1global strains, invasive M1UK strains exhibit reduced genomic diversity and fewer mutations in two-component regulator genes covRS. The emergence of M1UK is dated to 2008. Following a bottleneck coinciding with the COVID-19 pandemic, three emergent M1UK clades underwent rapid nationwide expansion, despite lack of detection in previous years. All M1UK isolates thus-far sequenced globally have a phylogenetic origin in the UK, with dispersal of the new clades in Europe. While waning immunity may promote streptococcal epidemics, the genetic features of M1UK point to a fitness advantage in pathogenicity, and a striking ability to persist through population bottlenecks.


Subject(s)
COVID-19 , Phylogeny , Streptococcal Infections , Streptococcus pyogenes , Streptococcus pyogenes/genetics , Streptococcus pyogenes/pathogenicity , Streptococcus pyogenes/isolation & purification , United Kingdom/epidemiology , Humans , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , COVID-19/epidemiology , Pandemics , Scarlet Fever/epidemiology , Scarlet Fever/microbiology , Mutation , Repressor Proteins/genetics , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Genome, Bacterial , Europe/epidemiology , Bacterial Proteins
17.
Euro Surveill ; 29(20)2024 May.
Article in English | MEDLINE | ID: mdl-38757285

ABSTRACT

At the end of 2022 and most notably during the first half of 2023, the number of invasive group A streptococcus (iGAS) notifications increased in Norway, largely affecting children younger than 10 years, as observed in several other countries. Following this atypical season, a new surge in the number of iGAS notifications began in December 2023 and peaked between January and February 2024, now particularly affecting both children younger than 10 years and older adults (70 years and above).


Subject(s)
Streptococcal Infections , Streptococcus pyogenes , Humans , Norway/epidemiology , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Aged , Child, Preschool , Child , Male , Female , Middle Aged , Adolescent , Incidence , Seasons , Aged, 80 and over , Infant , Adult , Age Distribution , Young Adult , Disease Notification/statistics & numerical data , Population Surveillance
18.
J Korean Med Sci ; 39(17): e154, 2024 May 06.
Article in English | MEDLINE | ID: mdl-38711318

ABSTRACT

The emergence of invasive infections attributed to group A Streptococcus (GAS) infections, has resurged since the 1980s. The recent surge in reports of toxic shock syndrome due to GAS in Japan in 2024, while sensationalized in the media, does not represent a novel infectious disease per se, as its diagnosis, treatment, and prevention are already well-established. However, due to signs of increasing incidence since 2011, further research is needed. Health authorities in neighboring countries like The Republic of Korea should not only issue travel advisories but also establish meticulous surveillance systems and initiate epidemiological studies on the genotypic variations of this disease while awaiting various epidemiological research findings from Japan.


Subject(s)
Shock, Septic , Streptococcal Infections , Streptococcus pyogenes , Humans , Shock, Septic/microbiology , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/genetics , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Republic of Korea , Japan , Superantigens/genetics , Anti-Bacterial Agents/therapeutic use , Enterotoxins/genetics
19.
Am Fam Physician ; 109(4): 343-349, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38648833

ABSTRACT

Group A beta-hemolytic streptococcal pharyngitis is a common infection responsible for more than 6 million office visits in the United States annually. Only 10% of adults seeking care for a sore throat have group A beta-hemolytic streptococcal pharyngitis; however, 60% or more are prescribed antibiotics. Guidelines recommend using clinical decision rules to assess the risk of group A beta-hemolytic streptococcal infection, followed by rapid antigen testing if a diagnosis is unclear, before prescribing antibiotics. Fever, tonsillar exudate, cervical lymphadenitis, and patient ages of 3 to 15 years increase clinical suspicion. A cough is more suggestive of a viral etiology. The limited history used in these decision rules is amenable to virtual visits. After a negative rapid antigen test result, a throat culture is recommended in children and adolescents. Penicillin and amoxicillin are first-line antibiotics, with a recommended course of 10 days; first-generation cephalosporins are recommended for patients with nonanaphylactic allergies to penicillin. There is significant resistance to azithromycin and clarithromycin in some parts of the United States. Steroids are not recommended for symptomatic treatment. Patients with worsening symptoms after appropriate antibiotic initiation or with symptoms lasting 5 days after the start of treatment should be reevaluated. Tonsillectomy is rarely recommended as a preventive measure: seven episodes of streptococcal pharyngitis in 1 year, five episodes in each of the past 2 years, or three episodes in each of the past 3 years are commonly used thresholds for considering surgery.


Subject(s)
Anti-Bacterial Agents , Pharyngitis , Streptococcal Infections , Streptococcus pyogenes , Humans , Pharyngitis/diagnosis , Pharyngitis/microbiology , Pharyngitis/drug therapy , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Streptococcus pyogenes/isolation & purification , Child , Practice Guidelines as Topic , Adolescent , United States/epidemiology , Adult
20.
Nat Commun ; 15(1): 3477, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38658529

ABSTRACT

Streptococcus dysgalactiae subspecies equisimilis (SDSE) and Streptococcus pyogenes share skin and throat niches with extensive genomic homology and horizontal gene transfer (HGT) possibly underlying shared disease phenotypes. It is unknown if cross-species transmission interaction occurs. Here, we conduct a genomic analysis of a longitudinal household survey in remote Australian First Nations communities for patterns of cross-species transmission interaction and HGT. Collected from 4547 person-consultations, we analyse 294 SDSE and 315 S. pyogenes genomes. We find SDSE and S. pyogenes transmission intersects extensively among households and show that patterns of co-occurrence and transmission links are consistent with independent transmission without inter-species interference. We identify at least one of three near-identical cross-species mobile genetic elements (MGEs) carrying antimicrobial resistance or streptodornase virulence genes in 55 (19%) SDSE and 23 (7%) S. pyogenes isolates. These findings demonstrate co-circulation of both pathogens and HGT in communities with a high burden of streptococcal disease, supporting a need to integrate SDSE and S. pyogenes surveillance and control efforts.


Subject(s)
Gene Transfer, Horizontal , Interspersed Repetitive Sequences , Streptococcal Infections , Streptococcus pyogenes , Streptococcus , Streptococcus pyogenes/genetics , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/classification , Streptococcal Infections/transmission , Streptococcal Infections/microbiology , Humans , Streptococcus/genetics , Streptococcus/isolation & purification , Interspersed Repetitive Sequences/genetics , Australia , Genome, Bacterial/genetics , Female , Male , Child , Family Characteristics , Adult , Child, Preschool , Adolescent , Longitudinal Studies , Drug Resistance, Bacterial/genetics , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL